Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Kyriacos Mitrophanous, Philip C. Buttery et al.|The Lancet|2014Cited by 436
Unilateral thalamic stimulation safely improved fragile X–associated tremor ataxia: A case reportSühan Senova, Stéphane Palfi, Naoki Tani et al.|Movement Disorders|2012Cited by 18
Paroxysmal positive symptoms caused by hardware malfunctioning in deep brain stimulationDaniel Ciampi de Andrade, Stéphane Palfi, Tomasz Mandat et al.|Brain stimulation|2009Cited by 3